Navigation Links
Statement from Lorillard Tobacco on FDA-Tobacco Regulation Legislation

GREENSBORO, N.C., April 3, 2008 /PRNewswire/ -- The Lorillard Tobacco Company today issued the following statement with regard to the passage of a bill by the House Committee on Energy and Commerce that would force the U.S. Food and Drug Administration (FDA) to regulate the tobacco industry.

"The Lorillard Tobacco Company opposes H.R. 1108 -- legislation that would force the FDA to regulate tobacco. While Lorillard fully supports reasonable federal regulation of the tobacco industry, the FDA already is overworked by Congress and is the wrong agency for the job. The challenges facing FDA are well documented. Adding a new industry for the FDA to oversee when it is struggling to fulfill its core mission is misguided. It will only compromise the health and safety of millions of Americans.

"This legislation also has fundamental problems. It would codify a 12-year-old FDA regulation that is blatantly unconstitutional, providing competitive advantage to our larger rivals. In addition, it makes the development and marketing of safer tobacco products impossible while providing no guidance to the FDA as to how to carry out this new regulation.

"It is important to note that FDA Commissioner Dr. Andrew von Eschenbach has made it abundantly clear that he does not believe FDA should be the agency to regulate tobacco. Tobacco is not a drug or device that should be regulated by the FDA. Forcing the FDA to depart from its core mission to regulate a product that is inherently dangerous is simply wrong."

SOURCE Lorillard Tobacco Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement by the White House Press Secretary
2. Statement in Response to SEIU United Healthcare Workers - Wests (UHW-W) Thursday Media Event
3. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
4. NCPA Statement on Californias Delay of E-Pedigree Implementation
5. American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM)
6. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
7. Pelosi Statement on Social Security and Medicare Trustees Reports
8. Media Alert: Statement on the Report of the Trustees of Social Security and Medicare
9. Statement from Kent Hill, USAID Assistant Administrator for Global Health, on the Observance of World Tuberculosis Day 2008
10. Statement By Robert McSwain, Acting Director, Indian Health Service, Regarding National Native HIV/AIDS Awareness Day 2008
11. PCMA Statement on Comparative Effectiveness
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: